Outcomes of selexipag for treatment of pulmonary arterial hypertension in an Asian population

被引：1
|
作者：
Loo, Germaine [1 ]
Yap, Jonathan [1 ,2 ,4 ]
Hon, Jin Shing [1 ]
Ismail, Aidila [1 ]
Ruan, Wen
Low, Andrea [3 ]
Lim, Soo Teik
Tan, Ju Le
机构：
[1] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore
[2] Duke NUS Med Sch, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore
[4] Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore
来源：
ANNALS ACADEMY OF MEDICINE SINGAPORE | 2023年 / 52卷 / 04期
关键词：
D O I：
10.47102/annals-acadmedsg.2022474
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：219 / 221
页数：3
相关论文
共 50 条
  • [1] Real-world outcomes of Selexipag for treatment of pulmonary hypertension in an Asian population
    Loo, G.
    Yap, J.
    Hon, J. S.
    Ismail, A.
    Lim, C. L.
    Sumanthy, P.
    Ruan, W.
    Sewa, D. W.
    Phua, G. C.
    Ng, S. A.
    Hong, C.
    Low, A.
    Lim, S. T.
    Tan, J. L.
    EUROPEAN HEART JOURNAL, 2023, 44 : 100 - 100
  • [2] Selexipag for the treatment of pulmonary arterial hypertension
    Skoro-Sajer, Nika
    Lang, Irene Marthe
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (03) : 429 - 436
  • [3] Selexipag for the treatment of pulmonary arterial hypertension
    Genecand, Leon
    Wacker, Julie
    Beghetti, Maurice
    Lador, Frederic
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (05) : 583 - 595
  • [4] Selexipag for the Treatment of Pulmonary Arterial Hypertension
    Sitbon, Olivier
    Channick, Richard
    Chin, Kelly M.
    Frey, Aline
    Gaine, Sean
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Hoeper, Marius M.
    Lang, Irene M.
    Preiss, Ralph
    Rubin, Lewis J.
    Di Scala, Lilla
    Tapson, Victor
    Adzerikho, Igor
    Liu, Jinming
    Moiseeva, Olga
    Zeng, Xiaofeng
    Simonneau, Gerald
    McLaughlin, Vallerie V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (26): : 2522 - 2533
  • [5] Selexipag for the treatment of pulmonary arterial hypertension
    Richter, Manuel Jonas
    Gall, Henning
    Grimminger, Jan
    Grimminger, Friedrich
    Ghofrani, Hossein-Ardeschir
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (13) : 1825 - 1834
  • [6] Selexipag for the treatment of pulmonary arterial hypertension
    Noel, Zachary R.
    Kido, Kazuhiko
    Macaulay, Tracy E.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (15) : 1135 - 1141
  • [7] Selexipag for the treatment of pulmonary arterial hypertension
    Sharma, Kamal
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 1 - 3
  • [8] Functional Outcomes Of Selexipag Versus Inhaled Treprostinil For The Treatment Of Pulmonary Arterial Hypertension
    Pallazola, V. A.
    Visovatti, S.
    McLaughlin, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension
    Sorensen, Louise M.
    Wehland, Markus
    Krueger, Marcus
    Simonsen, Ulf
    Nassef, Mohamed Z.
    Infanger, Manfred
    Grimm, Daniela
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (34) : 5191 - 5199
  • [10] Selexipag: A New Treatment Agent for Pulmonary Arterial Hypertension
    Yazici, Onur
    Gungor, Hasan
    MEANDROS MEDICAL AND DENTAL JOURNAL, 2019, 20 (01): : 1 - 6
12345